Cargando…
Halogenated Pyrrolopyrimidines with Low MIC on Staphylococcus aureus and Synergistic Effects with an Antimicrobial Peptide
Currently, there is a world-wide rise in antibiotic resistance causing burdens to individuals and public healthcare systems. At the same time drug development is lagging behind. Therefore, finding new ways of treating bacterial infections either by identifying new agents or combinations of drugs is...
Autores principales: | Olsen, Cecilie Elisabeth, Blindheim, Fredrik Heen, Søgaard, Caroline Krogh, Røst, Lisa Marie, Singleton, Amanda Holstad, Bergum, Olaug Elisabeth Torheim, Bruheim, Per, Otterlei, Marit, Sundby, Eirik, Hoff, Bård Helge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330635/ https://www.ncbi.nlm.nih.gov/pubmed/35892374 http://dx.doi.org/10.3390/antibiotics11080984 |
Ejemplares similares
-
Activation of multiple stress responses in Staphylococcus aureus substantially lowers the minimal inhibitory concentration when combining two novel antibiotic drug candidates
por: Singleton, Amanda Holstad, et al.
Publicado: (2023) -
“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling
por: Søgaard, Caroline Krogh, et al.
Publicado: (2018) -
The Nature of Diamino Linker and Halogen Bonding Define Selectivity of Pyrrolopyrimidine-Based LIMK1 Inhibitors
por: Ariawan, Daryl, et al.
Publicado: (2021) -
Changes in cellular signaling proteins in extracts from A549, H460, and U2OS cells treated with cisplatin or docetaxel
por: Petrovic, Voin, et al.
Publicado: (2017) -
PCNA regulates primary metabolism by scaffolding metabolic enzymes
por: Røst, Lisa M., et al.
Publicado: (2022)